Standard InChI: InChI=1S/C24H19N7O2S/c25-21(32)20-23(30-22(33)16-8-6-15(7-9-16)13-31-12-11-26-14-31)34-24(29-20)28-19-5-1-4-18-17(19)3-2-10-27-18/h1-12,14H,13H2,(H2,25,32)(H,28,29)(H,30,33)
2.McDermott, Ultan U and 24 more authors. 2007-12-11 Identification of genotype-correlated sensitivity to selective kinase inhibitors by using high-throughput tumor cell line profiling. [PMID:18077425]
3.Zarrinkar, Patrick P PP and 15 more authors. 2009-10-01 AC220 is a uniquely potent and selective inhibitor of FLT3 for the treatment of acute myeloid leukemia (AML). [PMID:19654408]
4.Klaeger, Susan S and 47 more authors. 2017-12-01 The target landscape of clinical kinase drugs. [PMID:29191878]
5.Narayan, Satya S and 7 more authors. 2019-01-01 ASR352, A potent anticancer agent: Synthesis, preliminary SAR, and biological activities against colorectal cancer bulk, 5-fluorouracil/oxaliplatin resistant and stem cells. [PMID:30384048]
6.Read, Jon J and 19 more authors. 2019-08-01 Tool inhibitors and assays to interrogate the biology of the TRAF2 and NCK interacting kinase. [PMID:31153805]
7.Nair, Satheesh and 39 more authors. 2020-07-09 Optimization of Nicotinamides as Potent and Selective IRAK4 Inhibitors with Efficacy in a Murine Model of Psoriasis. [PMID:32676146]